USD 129.75
(-0.75%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 175.18 Million USD | -1.61% |
2022 | 178.05 Million USD | -29.84% |
2021 | 253.77 Million USD | 10.15% |
2020 | 230.38 Million USD | 182.94% |
2019 | 81.42 Million USD | 371.11% |
2018 | 17.28 Million USD | -59.77% |
2017 | 42.95 Million USD | 71.75% |
2016 | 25.01 Million USD | 736.28% |
2015 | 2.99 Million USD | -18.35% |
2014 | 3.66 Million USD | 0.0% |
2013 | - USD | -100.0% |
2012 | 16.45 Million USD | -47.8% |
2011 | 31.52 Million USD | -30.23% |
2010 | 45.18 Million USD | -8.23% |
2009 | 49.23 Million USD | -22.06% |
2008 | 63.17 Million USD | 15.59% |
2007 | 54.65 Million USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 149.69 Million USD | -14.55% |
2024 Q2 | 49.58 Million USD | -66.88% |
2024 Q3 | 49.76 Million USD | 0.36% |
2023 Q2 | 133.25 Million USD | -18.04% |
2023 Q3 | 216.98 Million USD | 62.84% |
2023 Q4 | 175.18 Million USD | -19.26% |
2023 FY | 175.18 Million USD | -1.61% |
2023 Q1 | 162.58 Million USD | -8.69% |
2022 Q3 | 211.59 Million USD | -13.77% |
2022 Q2 | 245.38 Million USD | -19.79% |
2022 FY | 178.05 Million USD | -29.84% |
2022 Q1 | 305.94 Million USD | 20.56% |
2022 Q4 | 178.05 Million USD | -15.85% |
2021 Q4 | 253.77 Million USD | -0.18% |
2021 Q3 | 254.21 Million USD | 11.0% |
2021 Q2 | 229.02 Million USD | -0.61% |
2021 Q1 | 230.43 Million USD | 0.02% |
2021 FY | 253.77 Million USD | 10.15% |
2020 Q4 | 230.38 Million USD | 140.91% |
2020 FY | 230.38 Million USD | 182.94% |
2020 Q1 | 81.13 Million USD | -0.36% |
2020 Q3 | 95.63 Million USD | 31.6% |
2020 Q2 | 72.66 Million USD | -10.43% |
2019 Q3 | 72.77 Million USD | 45.22% |
2019 Q2 | 50.11 Million USD | 72.49% |
2019 FY | 81.42 Million USD | 371.11% |
2019 Q1 | 29.05 Million USD | 68.1% |
2019 Q4 | 81.42 Million USD | 11.89% |
2018 Q4 | 17.28 Million USD | -82.92% |
2018 Q2 | 101.85 Million USD | 141.6% |
2018 Q1 | 42.15 Million USD | -1.87% |
2018 Q3 | 101.2 Million USD | -0.63% |
2018 FY | 17.28 Million USD | -59.77% |
2017 Q3 | 43.77 Million USD | -0.59% |
2017 FY | 42.95 Million USD | 71.75% |
2017 Q4 | 42.95 Million USD | -1.87% |
2017 Q2 | 44.03 Million USD | 80.28% |
2017 Q1 | 24.42 Million USD | -2.34% |
2016 FY | 25.01 Million USD | 736.28% |
2016 Q4 | 25.01 Million USD | 0.18% |
2016 Q2 | 42.46 Million USD | 27.57% |
2016 Q1 | 33.28 Million USD | 1012.91% |
2016 Q3 | 24.96 Million USD | -41.2% |
2015 Q4 | 2.99 Million USD | -8.31% |
2015 FY | 2.99 Million USD | -18.35% |
2015 Q1 | 3.41 Million USD | -6.69% |
2015 Q3 | 3.26 Million USD | -7.62% |
2015 Q2 | 3.53 Million USD | 3.31% |
2014 Q1 | - USD | 0.0% |
2014 Q4 | 3.66 Million USD | -6.17% |
2014 Q2 | - USD | 0.0% |
2014 FY | 3.66 Million USD | 0.0% |
2014 Q3 | 3.9 Million USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q1 | - USD | -100.0% |
2013 Q2 | - USD | 0.0% |
2013 FY | - USD | -100.0% |
2012 FY | 16.45 Million USD | -47.8% |
2012 Q4 | 16.45 Million USD | -26.53% |
2012 Q3 | 22.4 Million USD | -12.24% |
2012 Q2 | 25.52 Million USD | -19.98% |
2012 Q1 | 31.9 Million USD | 1.19% |
2011 Q2 | 40.02 Million USD | 16.92% |
2011 Q3 | 34.65 Million USD | -13.43% |
2011 FY | 31.52 Million USD | -30.23% |
2011 Q4 | 31.52 Million USD | -9.02% |
2011 Q1 | 34.23 Million USD | -24.24% |
2010 Q1 | 48.58 Million USD | -1.32% |
2010 Q2 | 49.55 Million USD | 1.99% |
2010 FY | 45.18 Million USD | -8.23% |
2010 Q4 | 45.18 Million USD | -10.56% |
2010 Q3 | 50.52 Million USD | 1.95% |
2009 Q3 | 60 Million USD | -6.85% |
2009 FY | 49.23 Million USD | -22.06% |
2009 Q2 | 64.41 Million USD | 0.0% |
2009 Q4 | 49.23 Million USD | -17.94% |
2008 FY | 63.17 Million USD | 15.59% |
2008 Q4 | 63.17 Million USD | 0.0% |
2007 FY | 54.65 Million USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Acadia Healthcare Company, Inc. | 1.51 Billion USD | 88.404% |
AirSculpt Technologies, Inc. | 99.66 Million USD | -75.766% |
Amedisys, Inc. | 487.21 Million USD | 64.044% |
American Oncology Network, Inc. | 128.32 Million USD | -36.514% |
Astrana Health, Inc. | 321.01 Million USD | 45.429% |
Aveanna Healthcare Holdings Inc. | 1.49 Billion USD | 88.315% |
IMAC Holdings, Inc. | - USD | -Infinity% |
biote Corp. | 114.87 Million USD | -52.503% |
Cryo-Cell International, Inc. | 10.89 Million USD | -1507.76% |
Cross Country Healthcare, Inc. | 5.26 Million USD | -3226.03% |
COMPASS Pathways plc | 33.04 Million USD | -430.051% |
DocGo Inc. | 46.49 Million USD | -276.759% |
The Ensign Group, Inc. | 1.87 Billion USD | 90.638% |
Healthcare Services Group, Inc. | 43.63 Million USD | -301.471% |
InnovAge Holding Corp. | 113.03 Million USD | -54.98% |
Assure Holdings Corp. | 14.8 Million USD | -1083.262% |
The Joint Corp. | 16.73 Million USD | -946.811% |
LifeStance Health Group, Inc. | 511.04 Million USD | 65.721% |
Mobile-health Network Solutions Class A Ordinary Shares | 657.13 Thousand USD | -26558.53% |
ModivCare Inc. | 1.14 Billion USD | 84.634% |
NewGenIvf Group Limited | 332.55 Thousand USD | -52577.919% |
Novo Integrated Sciences, Inc. | 4.47 Million USD | -3817.615% |
Option Care Health, Inc. | 1.16 Billion USD | 84.981% |
P3 Health Partners Inc. | 124.64 Million USD | -40.549% |
P3 Health Partners Inc. | 124.64 Million USD | -40.549% |
The Pennant Group, Inc. | 329.63 Million USD | 46.855% |
Surgery Partners, Inc. | 3.06 Billion USD | 94.278% |
Syra Health Corp. Class A Common Stock | 248.1 Thousand USD | -70508.578% |
Talkspace, Inc. | - USD | -Infinity% |
Talkspace, Inc. | - USD | -Infinity% |
The Oncology Institute, Inc. | 119.81 Million USD | -46.21% |
The Oncology Institute, Inc. | 119.81 Million USD | -46.21% |